LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: COVID-19-Related Thrombosis in Japan: Final Report of a Questionnaire-Based Survey in 2020.

Horiuchi, Hisanori / Morishita, Eriko / Urano, Tetsumei / Yokoyama, Kenji

Journal of atherosclerosis and thrombosis

2021  Volume 28, Issue 4, Page(s) 406–416

Abstract: A questionnaire on COVID-19-related thrombosis in patients hospitalized before Aug 31, 2020, was ... thrombotic events. Thrombosis occurred in 32 patients with mild or moderate COVID-19 severity (0.59 ... 202 COVID-19 patients. Of these, 333 and 56 required ventilation or ...

Abstract A questionnaire on COVID-19-related thrombosis in patients hospitalized before Aug 31, 2020, was sent to 399 hospitals throughout Japan. Responses were received from 111 (27.8%) with information on 6,202 COVID-19 patients. Of these, 333 and 56 required ventilation or extracorporeal membrane oxygenation (ECMO), respectively, and 212 died (3.4%). D-dimer levels were measured in 75.0% of the patients, revealing that 9.2% and 7.6% exhibited D-dimer increases of 3-8-fold and ≥8-fold the reference value, respectively. Thrombotic events occurred in 108 patients (1.86% of the 5,807 patients with available data) including symptomatic cerebral infarction in 24, myocardial infarction in 7, deep vein thrombosis in 41, pulmonary thromboembolism in 30, and other thrombotic events in 22. Some patients developed multiple thrombotic events. Thrombosis occurred in 32 patients with mild or moderate COVID-19 severity (0.59% of those with data available) and in 52 patients on ventilation or ECMO (13.5% of severe patients for whom data were available). Thrombosis occurred in 67 patients during worsening clinical condition and in 26 during recovery. Anticoagulant therapy was provided to 893 patients (14.6% of the 6,119 patients with available data), the main reasons being provided as elevated D-dimer levels and worsening clinical condition.
MeSH term(s) Aged ; Anticoagulants/therapeutic use ; COVID-19/complications ; COVID-19/epidemiology ; Extracorporeal Membrane Oxygenation ; Female ; Fibrin Fibrinogen Degradation Products/analysis ; Hospitalization ; Humans ; Incidence ; Japan/epidemiology ; Male ; Middle Aged ; Myocardial Infarction ; Oxygen/metabolism ; Respiration, Artificial ; Surveys and Questionnaires ; Thrombosis/complications ; Thrombosis/epidemiology
Chemical Substances Anticoagulants ; Fibrin Fibrinogen Degradation Products ; fibrin fragment D ; Oxygen (S88TT14065)
Language English
Publishing date 2021-03-06
Publishing country Japan
Document type Journal Article
ZDB-ID 2011474-6
ISSN 1880-3873 ; 1340-3478
ISSN (online) 1880-3873
ISSN 1340-3478
DOI 10.5551/jat.RPT001
Shelf mark
Zs.A 5192: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top